New AMA Policy Endorses More Nuanced View Of BMI As Heightened Scrutiny Continues

• The AMA now says BMI should be considered alongside other measures for patient risk and care due to its limitations and history of racial bias.
• Some conservatives argue BMI remains an accepted measure and criticize the AMA as overly "woke."
• Genetic testing company 1Health.io faces FTC charges over allegedly failing to protect customer privacy.
• A COVID-19 infection may accelerate the risk of developing diabetes according to new studies.
• GSK's RSV vaccine provided long-term protection in older adults after one dose in a late-stage trial.

3 Articles

Forbes Forbes Essence